Cargando…
Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728735/ https://www.ncbi.nlm.nih.gov/pubmed/33330677 http://dx.doi.org/10.3389/fcvm.2020.616564 |
_version_ | 1783621333697953792 |
---|---|
author | Rubattu, Speranza Gallo, Giovanna Volpe, Massimo |
author_facet | Rubattu, Speranza Gallo, Giovanna Volpe, Massimo |
author_sort | Rubattu, Speranza |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7728735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77287352020-12-15 Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 Rubattu, Speranza Gallo, Giovanna Volpe, Massimo Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2020-11-27 /pmc/articles/PMC7728735/ /pubmed/33330677 http://dx.doi.org/10.3389/fcvm.2020.616564 Text en Copyright © 2020 Rubattu, Gallo and Volpe. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Rubattu, Speranza Gallo, Giovanna Volpe, Massimo Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 |
title | Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 |
title_full | Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 |
title_fullStr | Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 |
title_full_unstemmed | Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 |
title_short | Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 |
title_sort | sacubitril/valsartan: potential impact of arni “beyond the wall” of ace2 on treatment and prognosis of heart failure patients with coronavirus disease-19 |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728735/ https://www.ncbi.nlm.nih.gov/pubmed/33330677 http://dx.doi.org/10.3389/fcvm.2020.616564 |
work_keys_str_mv | AT rubattusperanza sacubitrilvalsartanpotentialimpactofarnibeyondthewalloface2ontreatmentandprognosisofheartfailurepatientswithcoronavirusdisease19 AT gallogiovanna sacubitrilvalsartanpotentialimpactofarnibeyondthewalloface2ontreatmentandprognosisofheartfailurepatientswithcoronavirusdisease19 AT volpemassimo sacubitrilvalsartanpotentialimpactofarnibeyondthewalloface2ontreatmentandprognosisofheartfailurepatientswithcoronavirusdisease19 |